Compass Financial Management LLC Purchases New Position in iShares U.S. Pharmaceuticals ETF $IHE

Compass Financial Management LLC acquired a new position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 5,627 shares of the company’s stock, valued at approximately $565,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Foundations Investment Advisors LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter worth $54,513,000. BNP Paribas Financial Markets purchased a new position in shares of iShares U.S. Pharmaceuticals ETF in the second quarter valued at $13,108,000. Anfield Capital Management LLC purchased a new position in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter valued at $10,007,000. JPMorgan Chase & Co. raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 89.4% during the 4th quarter. JPMorgan Chase & Co. now owns 212,805 shares of the company’s stock valued at $18,052,000 after purchasing an additional 100,426 shares during the period. Finally, Cetera Investment Advisers raised its stake in shares of iShares U.S. Pharmaceuticals ETF by 675.4% during the 1st quarter. Cetera Investment Advisers now owns 109,471 shares of the company’s stock valued at $9,489,000 after purchasing an additional 95,353 shares during the period.

iShares U.S. Pharmaceuticals ETF Stock Performance

Shares of IHE opened at $106.79 on Monday. The stock’s 50-day simple moving average is $100.41 and its 200 day simple moving average is $92.84. The stock has a market capitalization of $1.71 billion, a price-to-earnings ratio of 17.75 and a beta of 0.48. iShares U.S. Pharmaceuticals ETF has a 52-week low of $69.02 and a 52-week high of $108.66.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.